Cardiac autonomic imbalance Chinese herbal formula, acupuncture, heart rate variability, cardiac autonomic activity
Conditions
Interventions
the sham group received superficial needle insertion to a depth of 2 mm for 15 minutes. ,Two capsules of Chinese herbal formula were administered 4 hours prior to placebo acupuncture.,participants rec
anshan, China). The needle was twirled and rotated every 5 minutes to elicit sensations of soreness, numbness, distention, or radiation, which are considered indicative of effective needling.,Two caps
Sham Comparator Procedure/Surgery,Experimental Dietary Supplement,Experimental Procedure/Surgery,Experimental Other
sham,sham combined with herbal formula (sham+herb),acupuncture (AC),acupuncture combined with herbal formula (AC+herb)
Sponsors
Huachiew Chalermprakiet University
Eligibility
Sex/Gender
Male
Age
22 Years to 23 Years
Inclusion criteria
Inclusion criteria: Participants were eligible for inclusion if they met all of the following criteria: 1. Healthy male volunteers. 2.Students or individuals affiliated with Huachiew Chalermprakiet University. 3. Willing and able to provide written informed consent. 4. No history of diabetes mellitus, neuropathy, cardiac arrhythmia, or other cardiovascular diseases. 5. Not receiving any medication or treatment known to affect cardiac autonomic function. 6. Able to abstain from alcohol and caffeine consumption for at least 24 hours before the experimental session.
Exclusion criteria
Exclusion criteria: Participants were excluded if they met any of the following criteria: 1. History of diabetes mellitus. 2. History of peripheral or autonomic neuropathy. 3. Presence of cardiac arrhythmias or other cardiovascular diseases. 4. Current use of medications or treatments known to affect cardiac autonomic function or heart rate variability. 5. Consumption of alcohol or caffeine within 24 hours prior to the experimental session. 6. Inability or unwillingness to comply with study procedures. 7. Incomplete study participation or poor-quality ECG recordings unsuitable for HRV analysis.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| heart rate, heart rate variability 4 hr after drug administration Time and frequency domain of HRV that derive from ECG | — |
Secondary
| Measure | Time frame |
|---|---|
| blood presure 4 hr after drug administration Systolic blood pressure (SBP) and diastolic blood pressure (DBP) measured in mmHg using an sphygmomanometer before and after intervention. | — |
Countries
Thailand
Contacts
Public ContactJanpen Bangsumruaj
Huachiew chalermprakiet
Outcome results
None listed